Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>In vitro</i> and <i>In vivo</i> Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

15 Jan 2009

Abstract excerpt

PURPOSE: Poly (ADP-ribose) polymerase (PARP) inhibitors are undergoing clinical evaluation for cancer therapy. Because PARP inhibition has been shown to enhance tumor cell sensitivity to radiation, we investigated the in vitro and in vivo effects of the novel PARP inhibitor E7016. EXPERIMENTAL DESIGN: The effect of E7016 on the in vitro radiosensitivity of tumor cell lines was evaluated using clonogenic survival....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to PARP inhibition in cancer therapy
Share to Toxin Mechanisms and Immunotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19147766
DOI: 10.1158/1078-0432.ccr-08-2079

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>In vitro</i> and <i>In vivo</i> Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016PMID 19147766Read ↗

<i>In vitro</i> and <i>In vivo</i> Radiosensitization Induced by the DNA Methylating Agent TemozolomideSemantic proximity Read ↗

Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP InhibitorsSemantic proximity Read ↗

Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastomaSemantic proximity Read ↗

<i>In Vitro</i>Evaluation of Combined Temozolomide and Radiotherapy Using X Rays and High-Linear Energy Transfer Radiation for GlioblastomaSemantic proximity Read ↗

Chronically radiation-exposed survivor glioblastoma cells display poor response to Chk1 inhibitionSemantic proximity Read ↗

Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer DrugsSemantic proximity Read ↗

Reparative properties of human glioblastoma cells after single exposure to a wide range of X-ray dosesSemantic proximity Read ↗

Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?Semantic proximity Read ↗

A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cellsSemantic proximity Read ↗

Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth controlSemantic proximity Read ↗

Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in GlioblastomaSemantic proximity Read ↗

Enhanced efficacy of combined HDAC and PARP targeting in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.